Buy Hold Sell: 3 micro-cap buys (and 2 facing headwinds)

After a few months of episodes at the top end of town, the team here at Buy Hold Sell thought we would take a trip along the road less travelled.

Why? Well, micro caps are often under-researched, undervalued and underappreciated by investors. This means these stocks can potentially produce outsized returns - far greater than those seen in the large-cap end of the market.

But not all micro caps are created equal. These companies are often far less transparent, far less liquid, and can carry a hell of a lot more risk.

So in this episode, Livewire's Chris Conway makes his Buy Hold Sell debut alongside 1851 Capital's Chris Stott and Yarra Capital Management's Joel Fleming for a look at three undiscovered micro-cap gems.

Plus, they also each name one much-loved micro-cap with serious headwinds on the horizon.

Note: This episode of Buy Hold Sell was filmed on Wednesday, 14th September 2022. You can read an edited transcript below:

https://www.livewiremarkets.com/wires/buy-hold-sell-3-micro-cap-buys-and-2-facing-headwinds/

Timecodes:
0:00 - Intro
0:30 - Is Capitol Health (ASX: CAJ) a buy, hold or sell?
1:16 - Is College (ASX: ICT) a buy, hold or sell?
2:19 - Is SRG Global (ASX: SRG) a buy, hold or sell?
3:04 - Joel's pick: A micro-cap with serious headwinds on the horizon
3:31 - Chris' pick: A micro-cap with serious headwinds on the horizon